BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  VBL Therapeutics Announces Initiation of Phase 2 Clinical Trial of VB-201 on hsCRP, Important Inflammation-Related Biomarker for Cardiovascular, Other Chronic Inflammatory Diseases

  December 21, 2010

   · 

  1 min read
• Business

  PharmaGap Inc. Reports Early Results in Bladder Cancer; Announces Collaboration With Queen’s University to Pursue Development for Clinical Use

  December 21, 2010

   · 

  5 min read
• Business

  PX’Therapeutics to Open a new cGMP Cell Culture Production Facility

  December 21, 2010

   · 

  1 min read
• Biotech Bay

  A Letter From the President of Biomagnetics Diagnostics Corporation

  December 21, 2010

   · 

  1 min read
• Deals

  Spencer Pharmaceutical Receives $500,000 Deposit From Al-Dorra

  December 21, 2010

   · 

  2 min read
• Drug Development

  VistaGen Therapeutics, Inc. Announces Successful Completion of Initial Phase 1 Safety Study of AV-101 for Neuropathic Pain

  December 21, 2010

   · 

  1 min read
• BioMidwest

  Medtronic, Inc. Statement on Death of Winston Wallin

  December 21, 2010

   · 

  1 min read
• Biotech Bay

  Ophthalmic Imaging Systems’ Abraxas EMR Receives ONC-ATCB 2011/2012 Certification

  December 21, 2010

   · 

  5 min read
• Business

  Icagen, Inc. Announces Management Changes

  December 21, 2010

   · 

  1 min read
• Drug Development

  Incyte Corporation Says Cancer Drug INC424 Meets Goal In Phase 3 Study; Stock up 8.9% As of 10:55AM EST

  December 21, 2010

   · 

  9 min read